Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Cyclerion Therapeutics, Inc. (CYCN) had Return on Investments of -3.78% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.09M |
|
$-0.32M |
|
-- |
|
$0.09M |
|
$1.76M |
|
$-1.67M |
|
$1.35M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
$-1.67M |
|
$-1.67M |
|
3.07M |
|
3.07M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$4.02M |
|
-- |
|
$5.35M |
|
$9.37M |
|
$0.80M |
|
-- |
|
-- |
|
$0.80M |
|
$8.57M |
|
$8.57M |
|
$8.57M |
|
3.08M |
|
| Cash Flow Statement Financials | |
$-1.47M |
|
-- |
|
$1.25M |
|
$3.23M |
|
$3.01M |
|
$-0.23M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1797.85% |
|
-1797.85% |
|
-- |
|
-348.39% |
|
-348.39% |
|
$-1.47M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.18 |
|
508.06 |
|
-3.78% |
|
-3.78% |
|
-3.46% |
|
|
Return on Investments |
-3.78% |
$2.79 |
|
$-0.48 |
|
$-0.48 |
|